Literature DB >> 26790353

Diseases of dab (Limanda limanda): Analysis and assessment of data on externally visible diseases, macroscopic liver neoplasms and liver histopathology in the North Sea, Baltic Sea and off Iceland.

Thomas Lang1, Stephen W Feist2, Grant D Stentiford2, John P Bignell2, A Dick Vethaak3, Werner Wosniok4.   

Abstract

In the framework of the ICON project (Integrated Assessment of Contaminant Impacts on the North Sea), common dab (Limanda limanda) from seven offshore sampling areas in the North Sea, Icelandic waters and the western Baltic Sea were examined in 2008 for the presence of externally visible diseases and parasites (EVD), macroscopic liver neoplasms (tumours) (MLN) and histopathological liver lesions (LH). Methodologies applied followed standardised ICES and BEQUALM protocols. The EDV results revealed pronounced spatial variation, with dab from the central and northern North Sea sampling areas showing the highest disease prevalence. MLN were recorded only in North Sea dab from the German Bight, Firth of Forth and Ekofisk at a low prevalence. LH results revealed a dominant prevalence of non-specific, mostly inflammatory, lesions and a low prevalence of early toxicopathic non-neoplastic lesions, tumour pre-stages (foci of cellular alteration) and liver tumours. For the analysis and assessment of spatial variation of EVD, a Fish Disease Index (FDI) was calculated for individual dab, summarising data on the presence/absence of EDV, their severity grades, effects on the host and compensating for effects of length, sex and season. FDI data confirmed that the health status of North Sea dab from the offshore areas Dogger Bank, Ekofisk and Firth of Forth was significantly worse than in dab from the German Bight, Icelandic areas and the western Baltic Sea. An assessment of the disease data following ICES/OSPAR criteria was accomplished by applying established numeric background (BAC) and ecological assessment criteria (EAC) for EDV, MLN and LH. The combined assessment of the three disease categories indicated that health effects classified as unacceptable were rare and mainly affected dab from the North Sea. Based on the findings of the present study, it is recommended to monitor wild fish diseases in the context of assessing the impact of hazardous substances and other stressors on the marine environment. The Fish Disease Index (FDI) is regarded as a strong tool for disease data analysis and assessment, suitable as ecosystem health indicator.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biomonitoring; Common dab (Limanda limanda); Diseases; Environmental assessment; FDI; ICON

Mesh:

Year:  2015        PMID: 26790353     DOI: 10.1016/j.marenvres.2015.12.009

Source DB:  PubMed          Journal:  Mar Environ Res        ISSN: 0141-1136            Impact factor:   3.130


  4 in total

1.  Pathology of wild Norway rats in Vancouver, Canada.

Authors:  Jamie L Rothenburger; Chelsea G Himsworth; Krista M D La Perle; Frederick A Leighton; Nicole M Nemeth; Piper M Treuting; Claire M Jardine
Journal:  J Vet Diagn Invest       Date:  2019-03       Impact factor: 1.279

2.  Necropsy-based Wild Fish Health Assessment.

Authors:  Vicki S Blazer; Heather L Walsh; Ryan P Braham; Cheyenne Smith
Journal:  J Vis Exp       Date:  2018-09-11       Impact factor: 1.355

3.  Anisakid nematode species identification in harbour porpoises (Phocoena phocoena) from the North Sea, Baltic Sea and North Atlantic using RFLP analysis.

Authors:  Jan Lakemeyer; Ursula Siebert; Amir Abdulmawjood; Kathrine A Ryeng; Lonneke L IJsseldijk; Kristina Lehnert
Journal:  Int J Parasitol Parasites Wildl       Date:  2020-05-20       Impact factor: 2.674

4.  A multi-biomarker study on Atlantic salmon (Salmo salar L.) affected by the emerging Red Skin Disease in the Baltic Sea.

Authors:  Fabian G Weichert; Charlotte Axén; Lars Förlin; Pedro A Inostroza; Ulrike Kammann; Annikki Welling; Joachim Sturve; Noomi Asker
Journal:  J Fish Dis       Date:  2020-10-26       Impact factor: 2.767

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.